Guardian Pharmacy Services Inc (GRDN)

Currency in USD
41.20
-0.90(-2.14%)
Closed·
41.200.00(0.00%)
·
Advertisement
GRDN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
40.8042.95
52 wk Range
23.1448.33
Key Statistics
Prev. Close
42.1
Open
42.3
Day's Range
40.8-42.95
52 wk Range
23.14-48.33
Volume
314.24K
Average Volume (3m)
470.94K
1-Year Change
73.4737%
Book Value / Share
3.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GRDN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
49.86
Upside
+21.01%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 49.86
(+21.01% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
KeyBanc
Buy---New Coverage22/09/2026
Truist Securities
Buy51.00+23.79%47.00Maintain21/09/2026
Oppenheimer
Buy49.00+18.93%43.00Maintain07/08/2026
Truist Securities
Buy47.00+14.08%43.00Maintain17/06/2026
Oppenheimer
Buy43.00+4.37%38.00Maintain07/05/2026

Guardian Pharmacy Services Inc Earnings Call Summary for Q2/2026

  • Guardian Pharmacy Q2 revenue rose 2% to $351.2M, constrained by IRA pricing cuts; underlying growth would have been low double-digits without reimbursement pressure.
  • Adjusted EBITDA climbed 19% to $29.7M with margin expanding to 8.4%; gross margin improved to 22.8% despite elevated fuel costs and new site dilution.
  • Company raised full-year 2026 guidance: revenue now $1.43B-$1.45B (from $1.40B-$1.42B); adjusted EBITDA $129M-$131M (from $123M-$127M).
  • Guardian ended quarter with $90M cash and zero debt; management prioritizing M&A and greenfield expansion while awaiting Omnicare divestiture clarity.
  • Management expects H2 2026 revenue to decline low single-digits YoY from IRA headwinds, but underlying growth to remain high single-digits with Q4 margin lift from vaccines.
Last Updated: 06/08/2026, 22:18
Read Full Transcript

Earnings

Latest Release
07/08/2026
EPS / Forecast
0.29 / --
Revenue / Forecast
351.77M / --
EPS Revisions
Last 90 days

Compare GRDN to Peers and Sector

Metrics to compare
GRDN
Peers
Sector
Relationship
P/E Ratio
39.6x26.1x−0.3x
PEG Ratio
0.251.680.00
Price/Book
10.6x3.0x2.6x
Price / LTM Sales
1.8x0.6x3.0x
Upside (Analyst Target)
18.4%13.7%58.5%
Fair Value Upside
Unlock3.9%7.1%Unlock

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.27M19.38%516.73M
Other Institutional Investors
37.68M59.49%1.59B
Public Companies & Retail Investors
13.38M21.13%563.47M
Total
63.34M100.00%2.67B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bindley Capital Partners, LLC26.32%16,669,666701,793
FMR LLC5.12%3,241,588136,471

People Also Watch

59.75
PS
+8.89%
24.610
SPNT
+0.45%
24.36
XNCR
-4.96%
113.85
VCTR
-1.24%
52.66
FBK
+0.15%

FAQ

What Is the Guardian Pharmacy Services (NYSE: GRDN) Share Price Today?

The Guardian Pharmacy Services stock price today is 41.20 USD.

What Stock Exchange Does Guardian Pharmacy Services (GRDN) Trade On?

Guardian Pharmacy Services is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Guardian Pharmacy Services?

The stock symbol (also called a 'ticker') for Guardian Pharmacy Services is "GRDN."

What Is the Current Guardian Pharmacy Services Market Capitalisation?

As of today, Guardian Pharmacy Services (NYSE: GRDN) market cap is 2.67B USD.

What Is Guardian Pharmacy Services's (GRDN) Earnings Per Share (TTM)?

The Guardian Pharmacy Services EPS is currently 1.04 (Trailing Twelve Months).

When Is the Next Guardian Pharmacy Services Earnings Date?

Guardian Pharmacy Services's next earnings report will be released on 17/11/2026.

Is GRDN a Buy or Sell From a Technical Analyst Perspective?

Based on today's Guardian Pharmacy Services moving averages and other technical indicators, the daily buy/sell signal for GRDN stock is Sell.

How Many Times Has Guardian Pharmacy Services Stock Split?

Guardian Pharmacy Services has split 0 times. (See the GRDN stock split history page for full effective split date and price information.)

How Many Employees Does Guardian Pharmacy Services Have?

Guardian Pharmacy Services has 3600 employees, based on their latest Companies House report.

What is the current trading status of Guardian Pharmacy Services (NYSE: GRDN)?

As of 06/10/2026, Guardian Pharmacy Services (GRDN) is trading at a share price of 41.20 USD, with a previous close of 42.10 USD. The stock has fluctuated within a day range of 40.80 USD to 42.95 USD, while its 52-week range spans from 23.14 USD to 48.33 USD.

What Is Guardian Pharmacy Services (GRDN) Price Target According to Analysts?

The average 12-month price target for Guardian Pharmacy Services is 49.86 USD, with a high estimate of 52 USD and a low estimate of 47 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +21.01% Upside potential.

What Is the GRDN Premarket Price?

GRDN's last pre-market stock price is 42.11 USD. The pre-market share volume is 7,620.00, and the stock has decreased by 0.01, or 0.02%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.